Ascendis Pharma A (ASND) Asset Utilization Ratio (2015 - 2026)
Ascendis Pharma A (ASND) posted Asset Utilization Ratio of 0.62 for Q1 2026, down 12.49% sequentially from 0.71 in Q4 2025, and up 158.25% YoY from 0.24 in Q1 2025.
Ascendis Pharma A (ASND) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Ascendis Pharma A has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.62 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 158.25% year-over-year to 0.62 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.62 (up 158.25% YoY) and the FY2025 annual result came in at 0.34, up 68.62% from the prior year.
- Asset Utilization Ratio eased to 0.62 in Q1 2026 per ASND's latest filing, from 0.71 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.71 in Q4 2025 and troughed at 0.04 in Q4 2022.
- A 5-year average of 0.35 and a median of 0.24 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio soared 1044.42% in 2023, then plunged 60.25% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.04 in 2022, then jumped by 1044.42% to 0.51 in 2023, then plunged by 53.46% to 0.24 in 2024, then jumped by 201.82% to 0.71 in 2025, then declined by 12.49% to 0.62 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.62, 0.71, and 0.67 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | 0.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.62 |
| Dec 31, 2025 | 0.71 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.58 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 0.24 |
| Sep 30, 2024 | 0.53 |
| Jun 30, 2024 | 0.62 |
| Mar 31, 2024 | 0.61 |
| Dec 31, 2023 | 0.51 |
| Sep 30, 2023 | 0.18 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.08 |